There are four-pot- and psychedelic-related stock categories which I use to provide the clearest overview of the cannabis/psychedelic stock sector that is available anywhere. Below is a comparison of how each sub-category has performed in the last week, the last 6 weeks, and YTD and the stocks that have moved +/-5% last week.

1. The Pure-Play "Seed-to-Sale" Pot Stocks Index consists of two sub-sectors whose constituents derive 100% of their revenue from the marijuana sector, trade for at least US$1/share, and have a Market Capitalization of at least US$100M. It consists of 23 such constituents which, in total:

• was -1.4% last week
• has declined -5.8% over the past 6 weeks and
• is +19.5% YTD 

a) The Canadian Pure-Play Licensed Producers Pot Stock Sub-Category Index consists of 6 constituents which:

• was -5.3% last week, has declined -13.3% over the past 6 weeks, and is +17.1% YTD
  • Its constituents are: Canopy (CGC), Tilray (TLRY), Cronos  (CRON), Aurora (ACB), Organigram (OGI), and Hexo (HEXO).
    • The major mover (+/- 5%) has been Hexo which:
      • was -10.1% last week; has declined -30.4% over the past 6 weeks and is +35.9% YTD.

b) The American Pure-Play Multi-State Operators Pot Stock Sub-Category Index consists of 17 constituents which:

• was -1.4% last week, has declined -5.8% over the past 6 weeks, and is +19.5% YTD
  • Its constituents are: Curaleaf (CURLF), Green Thumb (GTBIF), Trulieve (TRSSF), Verano (VRNOF), Cresco (CRLBF), TerrAscend (TRSSF), Columbia (CCHWF), Harvest Health (HRVSF), Ascend Wellness (AAWH.U), Planet 13 (PLNHF), Ayr (AYRWF), Jushi  (JUSHF), 4 Front (FFNTF), Charlotte's Web (CWBHF), Gage (GAGE), Goodness Growth (GDNSF) and Acreage (ACRDF & ACRHF).
    • The major movers (+/- 5%) were:
      1. Columbia Care: +12.2% last week, -13.3% over the past 6 weeks, -13.2% YTD
      2. Charlotte's Web: -7.3% last week, -28.3% over the past 6 weeks, +3.6% YTD
      3. TerrAscend: -7.0% last week, -8.1% over the past 6 weeks, +5.5% YTD 

2. The Ancillary Pot Stock Sub-Category Index of 8 constituents tracks the performance of companies that provide goods and services to cannabis operators and have a Market Capitalization of at least US$100M and it

• was -0.5% last week, has declined -1.5% over the past 6 weeks and is +33.2% YTD
  • Its constituents are: AFC Gamma (AFCG), Forian (FORA), Grow Generation (GRWG), Hydrofarm (HYFM), Innovative (IIPR), Scotts Miracle-Gro (SMG), Turning Point (TPB), and Village Farms (VFF).
    • The major mover (+/- 5%) was:
      • Grow Generation which was -7.0% last week, has declined -8.1% over the past 6 weeks and is +5.5% YTD 

 3. The Pure-Play Marijuana & Mushroom Psychedelic Drug Stocks Sub-Category Index

Approximately 100 clinical-stage marijuana and mushroom/ketamine psychedelic drug stocks now trade on the various North American stock exchanges and they are more or less evenly divided between those researching the treatment of a variety of mental illnesses based on the use of "magic mushrooms" (psilocybin), ketamine, DMT, Ibogaine, LSD, or MDMA ("ecstasy") AND those researching the treatment of mental illnesses based on the use of THC marijuana.

The Index consists of 8 clinical-stage drug companies in each of the marijuana and mushroom categories and have market capitalizations in excess of $50M and less than $500M.

It consists of 16 constituents which, in total:

• was -0.2% last week
• has advanced +2.6% over the past 6 weeks and
• is +27.7% YTD 

a) The Marijuana-Based Category

• was -0.9% last week, has declined -8.5% over the past 6 weeks, and is +7.3% YTD
  • Its constituents are: Corbus (CRBP), Zynerba (ZYNE), MGC (MGCLF), Revive (RVVTF),  Zelira (ZLDAF), Tetra Bio (TBPMF), Allied Corp. (ALID), and Enveric (ENVB).
  • The major movers (+/- 5%) were:
    1. Enveric: +6.4% last week, +4.5% over the past 6 weeks and -45.3% YTD
    2. Tetro Bio: -11.1% last week, -22.6% over the past 6 weeks and +60.0% YTD
    3. Revive: -12.2% last week, +13.2% over the past 6 weeks and -12.2% YTD

b) The Mushroom/Ketamine-Based Category

• was -2.0% last week, has advanced +33.7% over the past 6 weeks, and is +54.7% YTD
  • Its constituents are: Mydecine (MYCOF), Red Light (TRUFF), Seelos (SEEL), Field Trip (FTRPF), Numinus (LKYSF), Small Pharma (DMTTF), Cybin (CLXPF), and Awakn Life (AWKN) 
  • The major movers (+/- 5%) were
    1. Cybin: +23.6% last week, +84.5% over the past 6 weeks and +74.7% YTD
    2. Mydecine: +15.2% last week, +35.7% over the past 6 weeks and +8.6% YTD
    3. Numinus: +10.8% last week, +7.9% over the past 6 weeks and -2.4% YTD 
    4. Field Trip: -5.5% last week, +16.2% over the last 6 weeks and +63.7% YTD 
    5. Seelos: -6.0% last week, -14.0% over the last 6 weeks and +67.7% YTD 
    6. Small Pharma: -8.3% last week and -8.3% in the last 6 weeks
    7. Awakn Life: -14.9% last week 
    8. Red Light: -23.3% last week, -8% in the last 6 weeks and -8% YTD 

4. The Conservative Pot Stock Index consists of 8 major tobacco, beer/liquor, big pharma, and convenience store constituents that have bought into marijuana companies, and compares their performances with those of their associated marijuana companies. The index was:

• was -1.2% last week, has declined -3.4% over the past 6 weeks, and is +5.9% YTD with an average dividend yield of 2.5%.
• its associated marijuana companies - Auxly (CBWTF) and Fire & Flower (FFLWF) - were -6.3% last week but are still +18.2% YTD, on average but payout no dividends.
• Its constituents are: Altria (MO), Imperial Brands (IMBBY), Novartis (NVS),  Constellation (STZ), Molson Coors (TAP), Anheuser Busch(BUD), Couche-Tard (ANCUF), and British American (BTI).
• No constituents had price changes of +/-5% last week.

The above 4 non-tradable indices replicate the performance of a portfolio investing an equal amount of money in each company in the various cannabis/psychedelic categories, with daily rebalancing to maintain equal weight.

Summary Performance

The 47 marijuana and psychedelic stocks tracked in the above indices were, on average:

• down -0.9% last week, have advanced -2.9% over the past 6 weeks, and are +18.3% YTD